05/02/2026
https://www.facebook.com/share/p/1E83Wb9ZGR/?mibextid=wwXIfr
Last year, my dad died from pancreatic cancer at 63. He tried with everything in him to get into a clinical trial for an experimental drug called daraxonrasib, but he was not accepted. Today, the FDA expanded access to the drug, making it available outside of clinical trials for the first time. The Lustgarten Foundation is one of the organizations that helped fund the research that led to this breakthrough. If you feel so inclined, please donate at the link in the comments to help prevent other families from having to go through what mine has.
